Sign in

CIK 0001022079

  • Large accelerated filer

QUEST DIAGNOSTICS INC

Sign in to watch
Ticker
DGX
Exchange
NYSE
Industry
Services-Medical Laboratories
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
161387862
Phone
+1 973-520-2700
Business address
500 PLAZA DRIVE, SECAUCUS, NJ, 07094
Former names
CORNING CLINICAL LABORATORIES INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$19,794,069
in 6 filings, $19.8M under 10b5-1 plans

Net −$19,794,069. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2020-02-24 EGLINTON MANNER CARRIE SVP, Advanced Diagnostics Shares withheld for taxes −515 $112.17 $58K 26,085
2020-02-24 RUSCKOWSKI STEPHEN H Chairman, CEO and President Shares withheld for taxes −2,404 $112.17 $270K 232,933
2020-02-24 Doherty Catherine T. SVP, Group Exec. Clin. Fran. Shares withheld for taxes −432 $112.17 $48K 71,106
2020-02-24 Mendez Manuel O. SVP & Chief Commercial Officer Shares withheld for taxes −123 $112.17 $14K 29,853
2020-02-24 GUINAN MARK Executive Vice President & CFO Shares withheld for taxes −653 $112.17 $73K 71,516
2020-02-18 DEPPE MICHAEL J VP, Corp. Controller & CAO Grant or award +776 24,619
2020-02-18 DEPPE MICHAEL J VP, Corp. Controller & CAO Grant or award · Non-Qualifed Stock Option (right to buy) +5,059 5,059
2020-02-18 RUSCKOWSKI STEPHEN H Chairman, President and CEO Grant or award +22,288 235,337
2020-02-18 RUSCKOWSKI STEPHEN H Chairman, President and CEO Grant or award · Non-Qualifed Stock Option (right to buy) +145,361 145,361
2020-02-18 PREVOZNIK MICHAEL E SVP & General Counsel Grant or award +3,477 42,455
2020-02-18 PREVOZNIK MICHAEL E SVP & General Counsel Grant or award · Non-Qualifed Stock Option (right to buy) +22,677 22,677
2020-02-18 Davis J. E. EVP, General Diagnostics Grant or award +6,152 42,695
2020-02-18 Davis J. E. EVP, General Diagnostics Grant or award · Non-Qualifed Stock Option (right to buy) +40,120 40,120
2020-02-18 Mendez Manuel O. SVP & Chief Commercial Officer Grant or award +5,350 29,976
2020-02-18 Mendez Manuel O. SVP & Chief Commercial Officer Grant or award · Non-Qualifed Stock Option (right to buy) +34,887 34,887
2020-02-18 GUINAN MARK Executive Vice President & CFO Grant or award +6,152 72,169
2020-02-18 GUINAN MARK Executive Vice President & CFO Grant or award · Non-Qualifed Stock Option (right to buy) +40,120 40,120
2020-02-18 Doherty Catherine T. SVP, Group Exec. Clin. Fran. Grant or award +4,012 71,538
2020-02-18 Doherty Catherine T. SVP, Group Exec. Clin. Fran. Grant or award · Non-Qualifed Stock Option (right to buy) +26,165 26,165
2020-02-18 EGLINTON MANNER CARRIE SVP, Advanced Diagnostics Grant or award +5,350 26,600

Page 45 of 52 · 1,040 trades